Found: 27
Select item for more details and to access through your institution.
Drug–Drug Interactions Mediated Through P-Glycoprotein: Clinical Relevance and In Vitro–In Vivo Correlation Using Digoxin as a Probe Drug.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 173, doi. 10.1038/clpt.2008.195
- By:
- Publication type:
- Article
Effects of Vitamin D Supplementation in Atorvastatin-Treated Patients: A New Drug Interaction With an Unexpected Consequence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 198, doi. 10.1038/clpt.2008.165
- By:
- Publication type:
- Article
Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 149, doi. 10.1038/clpt.2008.152
- By:
- Publication type:
- Article
Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109).
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 182, doi. 10.1038/clpt.2008.201
- By:
- Publication type:
- Article
Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 217, doi. 10.1038/clpt.2008.200
- By:
- Publication type:
- Article
Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 164, doi. 10.1038/clpt.2008.154
- By:
- Publication type:
- Article
From Darkness to Light With Biomarkers in Early Clinical Trials of Cancer Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 131, doi. 10.1038/clpt.2008.223
- By:
- Publication type:
- Article
The Price of Success: Cost-Effectiveness of Molecularly Targeted Agents.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 136, doi. 10.1038/clpt.2008.245
- By:
- Publication type:
- Article
The Increasing Complexity of Mercaptopurine Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 139, doi. 10.1038/clpt.2008.219
- By:
- Publication type:
- Article
Risk of Myocardial Infarction and Death Associated With the Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Among Healthy Individuals: A Nationwide Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 190, doi. 10.1038/clpt.2008.204
- By:
- Publication type:
- Article
Personalized Pharmacotherapy: Genotypes, Biomarkers, and Beyond.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Vascular Effects of RWJ-676070, a Selective Combined V<sub>1a</sub>/V<sub>2</sub> Vasopressin Receptor Antagonist.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 145, doi. 10.1038/clpt.2008.217
- By:
- Publication type:
- Article
A Textbook of Clinical Pharmacology and Therapeutics, 5th Edition.
- Published in:
- 2009
- By:
- Publication type:
- Book Review
Clinical Drug Development for Childhood Cancers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 127, doi. 10.1038/clpt.2008.237
- By:
- Publication type:
- Article
Pharmacokinetic Considerations for New Targeted Therapies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 208, doi. 10.1038/clpt.2008.242
- By:
- Publication type:
- Article
Biomarkers in Early Cancer Drug Development: Limited Utility.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 134, doi. 10.1038/clpt.2008.231
- By:
- Publication type:
- Article
Phase 0 Clinical Studies in Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 204, doi. 10.1038/clpt.2008.246
- By:
- Publication type:
- Article
Novel Clinical Trial Designs for Innovative Therapies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 212, doi. 10.1038/clpt.2008.247
- By:
- Publication type:
- Article
Declining Public Health Burden of Digoxin Toxicity: Decreased Use or Safer Prescribing?
- Published in:
- 2009
- By:
- Publication type:
- Letter
Response to “Declining Public Health Burden of Digoxin Toxicity: Decreased Use or Safer Prescribing?”.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Advances in Cancer Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 113, doi. 10.1038/clpt.2008.259
- By:
- Publication type:
- Article
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response.
- Published in:
- 2009
- By:
- Publication type:
- Book Review
CORRIGENDUM: Adolescents in Clinical Trials.
- Published in:
- 2009
- Publication type:
- Correction notice
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 120, doi. 10.1038/clpt.2008.265
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 118, doi. 10.1038/clpt.2008.267
- Publication type:
- Article
Pharmacogenetic Pathway Analysis of Docetaxel Elimination.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 155, doi. 10.1038/clpt.2008.95
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 2, p. 111, doi. 10.1038/clpt.2008.266
- Publication type:
- Article